Product image of Ms Contin (Morphine Sulfate Pentahydrate) supplied by GNH India

Ms Contin

Active Ingredient:
Morphine Sulfate Pentahydrate
Origin:
EU

Ms Contin (Morphine Sulfate Pentahydrate)

Morphine Sulfate, the active ingredient in Ms Contin, is an opioid analgesic presented as an extended‑release oral tablet for oral use. It treats moderate to severe pain, including chronic and cancer‑related pain, in adult patients.\n\nGNH India supplies Ms Contin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other health‑care institutions worldwide.

Manufacturer / TM Owner

Mundipharma Pharmaceuticals Bv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Ms Contin is an opioid analgesic used in the management of pain syndromes.\n\n- Moderate to severe pain: provides continuous analgesia for acute or breakthrough pain in adult patients.\n- Chronic non‑cancer pain: helps control long‑term pain where sustained relief is required.\n- Cancer‑related pain: alleviates severe pain associated with malignant disease, improving quality of life.

How It Works

  • Morphine Sulfate acts as a full agonist at mu‑opioid receptors in the central nervous system. By binding these receptors, it inhibits the transmission of nociceptive signals, reduces neuronal excitability, and alters the perception of pain, resulting in analgesia and sedation.

Side Effects

  • Common Side Effects:\n- Constipation: reduced gastrointestinal motility leading to hard stools.\n- Nausea: feeling of sickness often accompanying opioid therapy.\n- Drowsiness: sedation that may affect alertness.\n- Dry mouth: decreased salivation causing oral discomfort.\n\nSerious or Rare Side Effects:\n- Respiratory depression: slowed breathing that can be life‑threatening.\n- Severe hypotension: marked drop in blood pressure requiring medical attention.\n- Dependence or addiction: potential for misuse with prolonged exposure.

Precautions & Warnings

  • Ms Contin requires careful clinical monitoring and adherence to prescribing guidelines.\n\n- Dose titration: adjust dose gradually under medical supervision.\n- Respiratory status: monitor patients with compromised breathing function.\n- Concomitant CNS depressants: avoid or use with caution due to additive sedation.\n- History of substance abuse: assess risk before initiating therapy.\n- Pregnancy and lactation: evaluate benefits versus risks; data are limited.\n- Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Avoid Interactions

  • Ms Contin may interact with other medicines, altering its safety or effectiveness.\n\nMajor Interactions (Avoid):\n- CNS depressants (e.g., benzodiazepines, barbiturates): increased risk of respiratory depression.\n- MAO inhibitors: risk of severe hypertension or serotonin syndrome.\n- SSRIs or SNRIs: potential for serotonin syndrome.\n\nModerate Interactions (Monitor Closely):\n- Anticholinergics: may worsen constipation.\n- Diuretics: may enhance hypotensive effect.\n- HIV protease inhibitors: may increase morphine plasma concentrations.

Frequently Asked Questions

Ms Contin is an extended‑release oral tablet containing morphine sulfate. It is prescribed to manage moderate to severe pain, including chronic non‑cancer pain and pain associated with cancer, providing long‑lasting analgesia for adult patients.

Morphine sulfate is a full agonist at mu‑opioid receptors in the brain and spinal cord. By activating these receptors, it blocks the transmission of pain signals and alters pain perception, resulting in effective analgesia and a degree of sedation.

The appropriate dose of Ms Contin is individualized and determined by the prescribing clinician based on the patient’s pain severity, previous opioid exposure, and overall health status. Dosage adjustments are made according to clinical response and tolerability.

Safety data for Ms Contin in pregnancy and lactation are limited. Use during pregnancy or while breastfeeding should only occur if the potential benefit justifies the potential risk to the fetus or infant, and under close medical supervision.

To order Ms Contin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ms Contin provides extended‑release delivery of morphine, offering steadier plasma concentrations compared with immediate‑release opioids. This can reduce dosing frequency and improve pain control for chronic conditions, whereas short‑acting opioids may require multiple daily doses and can produce more peaks and troughs in pain relief.

Ms Contin tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure they are out of reach of children.

Ms Contin is taken orally as a whole tablet, without crushing, chewing, or splitting, to maintain its extended‑release properties. It is usually taken once every 12 hours, but the exact schedule is set by the prescribing healthcare professional.

The most serious risks include respiratory depression, severe hypotension, dependence or addiction, and rare events such as serotonin syndrome when combined with certain antidepressants. Patients should be monitored closely for signs of these adverse reactions, especially during dose initiation or escalation.

Ms Contin is contraindicated in patients with known hypersensitivity to morphine or any component of the formulation, those with significant respiratory depression, acute or severe asthma, and individuals who have taken MAO inhibitors within the past 14 days. It should also be used with caution in patients with severe hepatic or renal impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Morphine Sulfate Pentahydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT